炎症性肠病的治疗与管理进展(3)
[7] Suzuki Y,Iida M,Ito H,et al. Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis:a multicenter,randomized,double-blind,parallel-group study [J]. Intest Res,2016,14(1):50-59.[8] Doherty G,Katsanos KH,Burisch J,et al. European Crohn′s and Colitis Organisation Topical Review on Treatment Withdrawal (′Exit Strategies′) in Inflammatory Bowel Disease [J]. J Crohns Colitis ......
您现在查看是摘要页,全文长 2771 字符。